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Abstract
Background: Voluntary medical male circumcision (VMMC) is a key component of combination HIV-prevention
programmes. Several high-HIV-prevalence countries in sub-Saharan Africa, including Zimbabwe, are looking to scale
up VMMC activities. There is limited evidence on how a combination of social learning from peer education by a
role model with different behavioural incentives influences demand for VMMC in such settings.
Methods/Design: This matched-cluster randomised controlled trial with 1740 participants will compare two
behavioural incentives against a control with no intervention. In the intervention clusters, participants will
participate in an education session delivered by a circumcised young male (“role model”) on the risks of HIV
infection and the benefits from medical male circumcision. All participants will receive contributions towards
transport costs to access medical male circumcision at participating clinics. Via blocked randomisation, in the
intervention clusters participants will be randomly assigned to receive one of two types of incentives – fixed cash
payment or lottery payment – both conditional on undergoing surgical VMMC. In two sites, a community-led
intervention will also be implemented to address social obstacles and to increase support from peers, families and
social structures. Baseline measures of endpoints will be gathered in surveys. Follow-up assessment at 6 months will
include self-reported uptake of VMMC triangulated with clinic data.
Discussion: This is the first trial to pilot-test social learning to improve risk perception and self-efficacy and to
address the fear of pain associated with VMMC and possible present-biased preferences with front-loaded
compensations as well as fixed or lottery-based cash payments. This study will generate important knowledge to
inform HIV-prevention policies about the effectiveness of behavioural interventions and incentives, which could be
easily scaled-up.
Trial registration: This trial has been registered on ClinicalTrials.gov (identifier: NCT03565588). Registered on 21 June 2018.
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Background
Several studies have demonstrated the effectiveness of male
circumcision in reducing HIV incidence [1–3]. Following
these findings, voluntary medical male circumcision
(VMMC) is now a key component of combination HIV-
prevention programmes, especially in high-prevalence re-
gions of sub-Saharan Africa. Several countries have national
scale-up programmes to increase male circumcision rates.
The VMMC programme in Zimbabwe initially planned to
reach 80% coverage among young males (ages 15–29) by
2017. However, uptake was slow and by 2016 only 845,000
VMMCs had been reported [4]. The target date for achiev-
ing this goal has since been extended to 2021. Modelling
studies have shown that, in order to achieve 80% VMMC
coverage by 2018 among 13- to 29-year-old males, 2.17 mil-
lion VMMCs were required. In addition, 1.30 million other
VMMCs would be required between 2018 and 2025 to
maintain the 80% coverage [5]. The same study also
showed that, in the medium term (2025), prioritising 15- to
24-year-old males would have the greatest impact on HIV
incidence. High prevalence of HIV and low male circumci-
sion rates offer great potential for the scale-up of VMMC
in Zimbabwe.
However, studies have highlighted several barriers to
VMMC uptake. These include fear of pain, reluctance of a
relationship partner towards the procedure, cultural bar-
riers and, in the case of working-age men, loss of wages
on the days following the procedure because of their in-
ability to work [6]. Behavioural economics offers a further
explanation for low uptake of VMMC services based on
an individual’s time preferences. If an individual is
present-biased [7], uptake of VMMC is likely to be low
when the individual faces immediate costs (lost wages,
pain, and temporary abstinence) and uncertain future ben-
efits (reduced risk of HIV infection). It may be possible to
offset such a present bias by means of a peer making in-
formation about the future health benefits more salient at
the present and of a financial compensation to counterbal-
ance the immediate economic and psychological costs. Be-
havioural economics has also shown that individuals
overweight small-probability events such as winning a lot-
tery [8]. Therefore, the effects of a financial incentive may
be greater if, instead of a fixed monetary amount, a
lottery-based incentive is offered.
Previous studies offering only financial incentives have
found modest effects on VMMC uptake. Fixed incen-
tives for 25- to 49-year-old men showed a 7.4% increase
in VMMC uptake within 2 months [9] whereas lottery-
based incentives for 21- to 39-year-old men showed no
increase within 3 months [10, 11]. Accompanying quali-
tative studies found that participants reported the fear of
pain associated with VMMC as being one of the main
reasons individuals did not take up VMMC despite the
financial incentive. A recent study [12] found that
counselling through “role models” – circumcised young
men in a football-focussed intervention – resulted in a
7.6% increase in VMMC uptake amongst 14- to 20-year-
old males. This study highlights the role of social learn-
ing in enhancing “self-efficacy” [13] for VMMC and ex-
plores the possible combination of social learning and
behavioural incentives.
The purpose of this study is to evaluate the impact on
the uptake of VMMC of an interactive VMMC educa-
tion session offered by a circumcised “role model”, plus
a front-loaded contribution to transport costs for acces-
sing VMMC, along with either (1) a conditional fixed
economic incentive compensating for lost wages or (2) a
conditional lottery-based economic incentive compen-
sating for lost wages. In all the intervention groups, par-
ticipants will receive a contribution towards transport
costs up-front at the time of randomisation in an at-
tempt to offset the immediate psychological and eco-
nomic costs. All the financial compensations and lottery
prizes will be in the form of cash paid through mobile
phone payment systems.
Methods/Design
Study hypothesis
The study hypothesises that an VMMC education session
offered by a role model – a young male who has previously
benefited from VMMC services in this community – ad-
dressing the risks of HIV infection, the benefits of VMMC,
and the fear of pain associated with VMMC, together with
a front-loaded compensation off-setting present-biased
preferences, as well as a fixed or lottery-based conditional
financial incentive, will improve risk perception and in-
crease uptake of VMMC in HIV-negative young males.
Study design
This is a prospectively registered, three-arm, matched-
cluster, randomised controlled trial with single (outcome
assessor) masking, intention-to-treat analysis, and 6
months of follow-up (Fig. 1). The study is being imple-
mented in eight sites in Manicaland Province, east
Zimbabwe. The study will be implemented site by site.
In each study site, a census of all households in the
study clusters at baseline will be used to identify 15- to
29-year-old males who are resident within the study site.
A detailed individual questionnaire will collect informa-
tion on primary endpoints and then provider-initiated
HIV testing and counselling will be offered. Individuals
identified as eligible after this stage will be invited to
participate in the intervention.
In each site, two matched clusters of villages will be
created. Clusters will be randomly allocated to the
intervention arm or to the control arm. Within the
intervention clusters, individuals will be further ran-
domly assigned to receive one of two incentives:
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A. An education session offered (30min) by a
circumcised male “role model”, an immediate $5
contribution towards transport costs to the health
facility, and a $20 payment (about 2 days of wages),
conditional on being circumcised within 6 months, or
B. An education session (30 min) offered by a
circumcised male “role model”, an immediate $5
contribution towards transport costs, and the
following lottery-based financial incentive, condi-
tional on being circumcised within 6 months:
– 5% (1 in 20) chance of receiving $200 (about 10
times 2 days of wages)
– 95% (19 in 20) chance of receiving $10 (about 1
day’s wage)
In addition, in two of the eight sites, a
community-engagement intervention using commu-
nity conversations (CCs) [14, 15] will be imple-
mented to address social and cultural barriers to
taking up VMMC and support the above-mentioned
individual-level intervention.
Males in the control clusters will receive no inter-
vention over and above the current national standard
of care in Zimbabwe. In the study sites, standard of
care, which includes some VMMC demand creation
activities, comprises information, education and com-
munication (IEC) materials (including posters featur-
ing people such as famous musicians and soccer
players who have taken up VMMC) with additional
school and community outreach, social marketing, and
market-segmentation approaches being tried in some
areas. Population Services International functions as a
Fig. 1 Study design
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national-level partner of the Zimbabwe Ministry of
Health and Child Care (ZMoHCC) in this programme.
Until recently, the programme has focussed largely on
youth (10–19 years old).
Participant informed consent and data collection will
be carried out by trained research assistants. For minors,
consent will be sought first from a parent or guardian.
For those whose parent or guardian provided consent
for study participation, assent will then be obtained from
the minors prior to study enrolment. HIV testing will be
carried out by appropriately trained and accredited staff
following the standard procedures and testing algorithm
used in the ZMoHCC routine provider-initiated testing
and counselling (PITC) services. HIV field test results
will be returned to participants the same day as the sur-
vey interview. Participants who test HIV-positive will re-
ceive referrals to treatment services as appropriate and
according to national guidelines. Participants testing
HIV-negative will also receive post-test counselling, and
those in the intervention clusters will be invited to par-
ticipate in the interventions.
Statistical analyses will be carried out by researchers
blinded to group allocation. Prior to enrolment, all partici-
pants will provide written informed consent. All personal
data will be confidential. The study has obtained ethical
approvals from the Medical Research Council of Zimbabwe
(reference number: MRCZ/A/2243), the Biomedical
Research and Training Institute, Zimbabwe Institutional Re-
view Board (reference number: AP140/2017) and the Imper-
ial College London Research Ethics Committee (reference
number: 17IC4160).
Qualitative explorations
Formative qualitative explorations will be embedded into
different stages of the study. Formative consultations
with local stakeholders and a youth advisory board will
provide feedback on the intervention procedures, while
qualitative studies will contextualise study outcomes by
exploring local norms, experiences and perspectives con-
cerning VMMC. Participants for the qualitative studies
will be recruited from settings conveniently chosen be-
cause of their rural/urban location and for being subject
to both VMMC and CC interventions – allowing a con-
trast of experiences. Forty young males from the two
settings will be invited to participate in either individual
interviews (n = 12), focus group discussions (n = 18) or
participatory photography (n = 10) with the aim of re-
vealing how they encounter, respond to and negotiate
VMMC uptake. The young males will be chosen from
the baseline survey by purposeful sampling following the
criteria that they have to be between the age of 15 and
29, HIV-negative, sexually active, considered “at risk”
(according to a World Health Organization risk screen-
ing tool), agreed to be contactable and volunteered to
participate. In addition, the young males will be sampled
to represent a mix of VMMC intervention experiences
to explore their reasons and motivations to participate
(or otherwise) in the intervention. Individual interviews
with parents of young males (n = 8), HIV-prevention
service providers (n = 12), focus groups with community
members (n = 6; about 36 participants) and men age 40
and above (n = 6; about 36 participants) will also be con-
ducted to gain insight into the broader social context of
VMMC and male-friendly HIV-prevention services.
Qualitative studies with 40 adolescent girls and young
women (AGYW) will also be conducted to provide add-
itional insight into the context that might affect young
men’s motivation to take up VMMC. The proposed
sample sizes are estimates deemed sufficient to reach
theoretical saturation. Transcriptions of the qualitative
data will be imported into NVivo 12, a computer-
assisted qualitative analysis software, for thematic net-
work analysis [16]. Attention will be paid to the social
practices that shape young men’s uptake of VMMC [17]
and factors determining progression along the HIV-
prevention cascade (HPC) [18].
Study setting
The study is being conducted in the Manicaland prov-
ince (in east Zimbabwe), which covers an area of 36,459
km2 (14,077 square miles) and has a population of about
1.75 million (2012). Six sites enumerated in a general
population cohort survey that ran from 1998 to 2013
[19] – two small towns, two large agricultural estates
and two rural villages – will be included in the study, to-
gether with two new sites in a high-density urban suburb
in Mutare, the provincial capital. The total estimated
population size in these areas is 35,760 people. Data
available from previous surveys in six study sites in-
cluded in the current study show that, in 2012–13, HIV
prevalences were 13.5% for males aged 15–54 years and
18.8% for females aged 15–54 years.
Intervention procedures
Research assistants will visit households to recruit study
participants. Informed consent will be sought on a one-
to-one basis at the respondent’s household or in another
private space. Research assistants will describe the study,
including its potential risks for the participants and the
potential benefits for participants and the local commu-
nity, and will answer all questions about the study that
household members may raise. When an eligible mem-
ber of a household agrees to participate in the study, he
or she will be invited to a central location where the sur-
veys and research activities will take place. The surveys
and research activities will take place at health facilities
or at nearby venues (e.g. community halls) close to clus-
ters of villages within each study site. The surveys will
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be administered in a private space on a 1:1 basis by
using digital tablets. At the start of the intervention, re-
search assistants will explain the intervention to the par-
ticipants within the intervention clusters. Participants
will be informed that they will be participating in an
education session on VMMC, followed by random as-
signment into one of the two treatment groups. Partici-
pants will be told that they will receive incentives if they
take up VMMC. In addition, an explanation on the
chances of winning the incentive lottery prizes will be
provided.
All consenting participants will be included in the edu-
cation sessions. The sessions will be held in groups of
about 10–20 participants. The sessions will be imple-
mented by “messengers” or “role models”, aged 18–30
years, who have undergone VMMC.
During each education session, detailed information
on the following will be provided:
 Communication of the risks of HIV infection
 Communication of the effectiveness of VMMC in
reducing the risks of HIV infection
 A “personal experience” narration about the role
model’s own experience in undergoing and
recovering from VMMC, followed by a question-
and-answer period
Following the education session, research assistants
will:
 Ask each participant to choose a scratch card, which
reveals their assignment to an intervention arm. The
scratch card will also serve as a VMMC referral card
to a participating study clinic where surgical VMMC
is available.
 Explain to the participant the referral card and
allocated compensation.
 Emphasise that the referral card and compensation
are valid for a period of only 6 months.
 Provide information about the participating clinics
in the study area where surgical VMMC services
will be available free of charge.
Each scratch card will have a unique identification
number, which will be matched to their baseline sur-
vey information. When participants attend for circum-
cision and present their referral cards, participating
study clinics will retain a section of the referral card.
Research assistants will verify that the circumcision
procedure was performed by consulting with clinic
staff and collect the submitted referral slips. They will
then provide participants with the compensation cor-
responding to their study group via mobile money.
This article adhered to the Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT)
2013 checklist (see Additional file 1 and Fig. 2).
Further procedures for clusters with community-led
interventions
A participatory reflection and action (PRA) approach to
community engagement will be introduced to tackle so-
cial barriers to uptake of VMMC. The approach of in-
volving local community structures in addressing health
challenges is based on strong theoretical foundations
[20, 21] and has been applied successfully in other health
programmes [22–24] and to tackle gender-based vio-
lence in the context of HIV [25]. This approach supports
critical thinking and problem solving around key com-
munity issues through CCs. CCs involve posing ques-
tions and thinking points to formal community groups
or informal networks around community challenges and
about potential local responses and community re-
sources to tackle these. In Zimbabwe, CCs have helped
to raise community HIV competence [26]. This study
will be the first to explore whether and how CCs – as a
community engagement strategy – can break down
community-level barriers with implications for VMMC
uptake. In these clusters, the Diocese of Mutare Com-
munity Care Programme (DOMCCP) will initiate and
support a process to (1) mobilise and work with pre-
existing village structures and local community groups
that have demonstrated a commitment to fight HIV
[27], (2) conduct CCs with formal groups at the village
level and generate community action plans, and (3) pro-
vide modest funding and technical support to commu-
nity groups to implement their planned activities. The
toolkit has been designed to complement the VMMC
intervention by (1) instigating discussions on HIV risk
and cementing the salience of HIV-prevention methods
and on social preferences and biases to uptake of
VMMC, (2) identifying innovative community-led solu-
tions that help AGYW and young males overcome social
barriers and re-think risk perceptions, and (3) develop-
ing clear steps for communities to prevent the spread of
HIV, drawing on local knowledge, resources and existing
local activities. Practically, each CC will comprise 10–15
people who, through four meetings, will (1) share their
thoughts and experiences of HIV risk and prevention
methods, (2) discuss the challenges and factors prevent-
ing AGYW and young males from using HIV-prevention
methods, (3) explore how to respond, and (4) develop
community action plans that correspond to local needs
and resources. The participants can be members of any
formal group or informal network of people (regardless
of age and gender) who at a community level may be
able to affect young men’s motivation and access to
VMMC services. The facilitation will be carried out by
“community conversation facilitators” who have been
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recruited and trained by the DOMCCP. The facilitators
will be local to the communities in which CCs will be
implemented and recruited because of their engagement
in HIV-prevention work. The CC groups will be sup-
ported by the DOMCCP to implement their action
plans.
Inclusion and exclusion criteria
A total of 1740 males will be enrolled on the basis of the
following eligibility criteria: (i) if they are between 15
and 29 years of age, (ii) they live in Manicaland province,
and (iii) they expect to be resident for the duration of
the study. Participants will be excluded if they test HIV-
positive at baseline or self-report that they have already
been circumcised. To avoid indirect disclosure of the
status of HIV-positive individuals, a random sample of
90% of HIV-negative males will be selected to participate
in the intervention.
Randomisation/masking
Within each study site, two matched clusters of villages will
be created on the basis of socio-economic characteristics
and factors such as distances to trading centres, major
roads and health centres. Control and intervention clusters
Fig. 2 Study schedule of events
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will be constructed to maximise the distance between them
to limit potential contamination. Clusters will be randomly
allocated to intervention or control. Males in the interven-
tion clusters will receive the intervention. Males in the con-
trol clusters will receive no intervention. Males in both
clusters will be followed up for measurement of outcomes
at 6months. For the allocation to one of the two treatment
groups, blocked randomisation will be used. Blocks of four
will be computer-generated and allocated to one of the two
treatment arms in a 1:1 ratio. Study staff will be blinded to
a block number and the sequence in a block. The treat-
ments will be assigned by using pre-prepared scratch cards
that individuals will be asked to select from a set of cards.
These cards will also serve as the VMMC referral docu-
mentation at participating clinics. Participants will not be
blinded from their allocated trial arm due to cluster level
randomisation and the nature of the intervention. Study in-
terventions and measurements will occur in separate loca-
tions and time points, thus facilitating the blinding of
outcome assessors.
Primary and secondary outcomes
HPCs have been proposed to facilitate (i) identification
of gaps in implementation of primary HIV-prevention
methods, (ii) understanding of the reasons for these
gaps, and (iii) identification and evaluation of promising
interventions to address the gaps [28, 29]. Preliminary
analysis of HPCs populated using existing study data
motivated the selection of some of the outcomes for this
study. The analysis found that the low levels of uptake
of VMMC in the study population were due largely to
low-risk perception for HIV infection – suggesting gaps
in motivation [28]. The primary outcome for the study
will be the proportion of males taking up VMMC within
6 months measured with self-reports in a follow-up sur-
vey conducted after 6 months and confirmed with clinic
data. The secondary outcomes will be risk perception –
measured in the baseline and follow-up surveys – and
self-reported sexual behaviour (e.g. condom use and
multiple partners) change measured between the base-
line and follow-up surveys.
Sample size estimates
It is estimated that a sample size of 580 participants per
arm will be necessary to detect meaningful minimum
effect sizes for the primary endpoint (VMMC uptake).
Survey data from the study sites in 2012–13 were used
to calculate the mean cluster size, the coefficient of
variation in cluster size (0.17 for males), and the intra-
cluster correlation coefficient (0.04 using HIV incidence
as the outcome). A baseline prevalence estimate for the
endpoint indicator (VMMC) was taken to be 30%. It
was also assumed that 80% of eligible participants will
consent to participate and a further 80% will be
followed up at 6 months. The community-led CC inter-
vention will be implemented in the “intervention clus-
ters” in addition to the individual-level VMMC
intervention. It will take place in only two cluster pairs,
and the analysis will examine the effects of the inter-
ventions within these two cluster pairs only so as to
allow greater power to detect the effect of the
individual-level intervention without CCs. Nevertheless,
in the two sites with the combined interventions, the
study is powered to detect large impacts on outcome
indicators. As a further consequence, there will not be
sufficient power to examine the interaction of the effect
sizes with and without the addition of the community-
level intervention. CCs have been included for explora-
tory and qualitative reasons, helping us understand the
role of social context in shaping uptake of VMMC, for
which we consider two sites sufficient.
Statistical analysis
Analysis of the primary outcome will be carried out on
an intention-to-treat basis. For each endpoint, a linear
regression will be used to estimate differences in the
cluster-level prevalence of the indicator at follow-up.
Any indicators unbalanced at baseline will be included
as covariates. The Shapiro–Wilk normality test will be
used to test for non-normality of the model residuals,
and standard non-parametric tests (e.g. Mann–Whitney
rank-sum test) will be used in case of non-normality. Ef-
fect sizes will be reported with 95% confidence intervals,
and results will be considered significant if the P value is
less than 0.05. Data will be analysed by using STATA.
Discussion
This trial will evaluate the impact of an education inter-
vention around HIV risks combined with an up-front
compensation and conditional incentives to modify be-
haviour (uptake of VMMC) delivered through fixed or
lottery mechanisms in improving perception of HIV risk
and uptake of VMMC amongst males aged 15–29 years.
The study will provide reliable and high-quality esti-
mates of the average treatment effects since it is a ran-
domised and prospectively registered study. Outcome
assessors will be masked, and the analysis will be based
on an intention-to-treat approach. Sample size was cal-
culated to provide adequate statistical power to identify
possible differences in the study’s primary outcome. In
addition, the 6-month follow-up will allow adequate
time for participants to take time off work and present
at clinics with referral vouchers for VMMC. The 6-
month follow-up period is also not too long to measure
adjustment in risk perception. Findings from the study
will help determine which type of financial incentive is
an effective tool to create demand for VMMC and to ad-
just HIV risk perceptions.
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The present study makes several innovative contribu-
tions. It combines social learning to improve HIV risk
perception and self-efficacy with behavioural incentives
and addresses the fear of pain associated with VMMC
and possible present-biased preferences with front-
loaded compensations as well as with fixed and lottery-
based conditional financial incentives. It is thus evaluat-
ing the effectiveness of this combination of different pre-
vention interventions in increasing uptake of VMMC in
uncircumcised males aged 15–29 years.
This study has limitations. The study does not test the
impact of not providing up-front contributions to trans-
port costs or the impact of the education session alone.
Another potential limitation is the possibility of lower-
than-expected retention rates as males may move away
for employment. Any retention challenges will provide
valuable information in planning for future research and
intervention implementation. Other limitations of this
randomised controlled trial could include recruitment
challenges and potential sampling bias. Eligibility, re-
cruitment, enrolment and retention will be closely moni-
tored to overcome such challenges.
To achieve the Sustainable Development Goal of ending
the AIDS epidemic as a public health threat by 2030, con-
siderable expansions of HIV-prevention efforts are
needed. Different demand creation activities must be con-
sidered. This study will generate important knowledge to
inform HIV-prevention policies about the effectiveness of
behavioural incentives which could be easily scaled-up.
Given that the costs of the intervention are incurred only
once, policy-makers could consider such an intervention,
if successful, to be implemented as national campaigns
promoted through health facilities at the time of HIV test-
ing or, more generally, as part of health campaigns. In
addition, this study will test the usability and acceptability
of mobile payments to make payment logistics simpler.
These results will be applicable not only to Zimbabwe but
also to other settings with high HIV prevalence.
Trial status
This trial was registered on clinicaltrials.gov (identifier:
NCT03565588) on 21 June 2018. https://clinicaltrials.
gov/ct2/show/study/NCT03565588. Recruitment com-
menced on 7 July 2018 and was expected to be com-
pleted by 31 December 2019. Follow-up data collection
will be completed by 31 August 2020. Protocol version
1.6, 19 April 2019.
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